All Stories

  1. Overexpression of Efflux Pump Genes is an Alternative Mechanism in Voriconazole Resistant Aspergillus fumigatus isolates Without Relative Mutations in CYP5A
  2. First azole‐resistant Aspergillus fumigatus isolates with the environmental TR 46 /Y121F/T289A mutation in Iran
  3. Highly Concentrated Multifunctional Silver Nanoparticle Fabrication through Green Reduction of Silver Ions in Terms of Mechanics and Therapeutic Potentials
  4. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  5. Interactions between immune response to fungal infection and microRNAs: The pioneer tuners
  6. New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study
  7. In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra
  8. A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus
  9. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients
  10. Candida auris otomycosis in Iran and review of recent literature
  11. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  12. Epidemiology of Aspergillus species causing keratitis in Mexico
  13. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  14. Comparative virulence of Candida auris with Candida haemulonii , Candida glabrata and Candida albicans in a murine model
  15. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  16. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  17. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  18. Evaluation of PCR-reverse line blot hybridization assay for simultaneous identification of medically important saprophytic fungi
  19. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients
  20. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  21. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review
  22. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
  23. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  24. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates
  25. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Clinical Samples
  26. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study
  27. Coexistence of aspergilloma and pulmonary hydatid cyst in an immunocompetent individual
  28. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus
  29. In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives
  30. In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
  31. Consistent high prevalence of Exophiala dermatitidis , a neurotropic opportunist, on railway sleepers
  32. Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis
  33. Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature
  34. Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana
  35. Disseminated Nocardiosis in an Immunocompetent Individual Infected with Nocardia brasiliensis, an Opportunistic Agent
  36. Activities of Novel Azoles against Candida spp.
  37. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata
  38. Is human dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?
  39. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  40. Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
  41. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
  42. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling
  43. In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus , an opportunistic fungal pathogen
  44. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  45. In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
  46. Mucormycosis in Iran: a systematic review
  47. Genotyping of clinical and environmentalAspergillus flavusisolates from Iran using microsatellites
  48. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  49. Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review
  50. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex
  51. Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species
  52. cyp51Agene silencing using RNA interference in azole-resistantAspergillus fumigatus
  53. Cryptococcal meningitis due toCryptococcus neoformansgenotype AFLP1/VNI in Iran: a review of the literature
  54. In VitroSusceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium
  55. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran
  56. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis
  57. Use of Padlock Probes and Rolling Circle Amplification (RCA) for Rapid Identification of Trichophyton Species, Related to Human and Animal Disorder
  58. Use of Restriction Fragment Length Polymorphism to Rapidly Identify Dermatophyte Species Related to Dermatophytosis
  59. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents
  60. In vitrosusceptibility patterns of clinically importantTrichophytonandEpidermophytonspecies against nine antifungal drugs
  61. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA
  62. Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran
  63. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis
  64. First Autochthonous Coinfected Anthrax in an Immunocompetent Patient
  65. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity
  66. A reappraisal of orders and families within the subclass Chaetothyriomycetidae (Eurotiomycetes, Ascomycota)
  67. Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii
  68. Cladophialophora abundans, a novel species of Chaetothyriales isolated from the natural environment
  69. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser
  70. Environmental study of azole‐resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran
  71. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba
  72. Severe Disseminated Phaeohyphomycosis in an Immunocompetent Patient Caused by Veronaea botryosa
  73. Use of Rolling Circle Amplification to Rapidly Identify Species of Cladophialophora Potentially Causing Human Infection
  74. Veronaea botryosa: Molecular Identification with Amplified Fragment Length Polymorphism (AFLP) and In vitro Antifungal Susceptibility
  75. An unusual case of eumycetoma caused byExophiala jeanselmeiafter a sea urchin injury
  76. In VitroAntifungal Susceptibility of Cladophialophora carrionii, an Agent of Human Chromoblastomycosis
  77. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum
  78. Molecular characterisation and pathogenicity ofPhaeoacremoniumspp. associated with esca disease of grapevine in Northern Iran
  79. Molecular Tools in Medical Mycology; Where We Are!
  80. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran
  81. Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient
  82. Waterborne Exophiala species causing disease in cold-blooded animals
  83. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist
  84. Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons
  85. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic
  86. Melanization of a Meristematic Mutant of Fonsecaea monophora Increases Tolerance to Stress Factors While no Effects on Antifungal Susceptibility
  87. Fatal Cerebral Phaeohyphomycosis in an Immunocompetent Individual Due to Thielavia subthermophila
  88. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi
  89. Rhinocladiella aquaspersa , proven agent of verrucous skin infection and a novel type of chromoblastomycosis
  90. Use of Amplified Fragment Length Polymorphism To Identify 42 Cladophialophora Strains Related to Cerebral Phaeohyphomycosis with In Vitro Antifungal Susceptibility
  91. The clinical spectrum of Exophiala jeanselmei , with a case report and in vitro antifungal susceptibility of the species
  92. Successful treatment of chromoblastomycosis of 36 years duration caused byFonsecaea monophora
  93. In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp.
  94. First Autochthonous Case of Rhinocladiella mackenziei Cerebral Abscess Outside the Middle East
  95. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection
  96. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species
  97. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species
  98. Cladophialophorasaturnicasp. nov., a new opportunistic species ofChaetothyrialesrevealed using molecular data
  99. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora
  100. Genetic diversity and species delimitation in the opportunistic genusFonsecaea
  101. Seroepidemiological Study for Toxocariasis among Children in Zanjan-Northwest of Iran
  102. Biodiversity of the genus Cladophialophora
  103. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico
  104. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species
  105. Fungal Contamination in Indoor Swimming Pools in Zanjan-Iran 2005